The U.S. Food and Drug Administration has approved Vizz 1.44% (aceclidine ophthalmic solution) for the treatment of ...

The FDA has approved VIZZ eye drops (LENZ Therapeutics, Inc.) for the treatment of presbyopia, the gradual loss of near ...

FDA approval was based on phase 3 trials showing significant tear production increase as early as Day 1.

The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, ...

Tryptyr (acoltremon ophthalmic solution) 0.003% is now available for the treatment of the signs and symptoms of dry eye ...

Investigators evaluated the clinical benefit of a sustained‐release dexamethasone intravitreal implant as a second‐line ...